Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, August 25, 2026

Snapshot: Aug 25, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Tue, Aug 25, 2026 Divergent High

Market whipsawed on extreme single-stock dispersion with healthcare surging 36% of gainers while industrials anchored 35% of losers, leaving major indices fractionally mixed.

55% Extreme dispersion dominated the day: 50 gainers averaged +30%, led by NCPL (+87%), while 50 losers averaged -26%, with GPAC collapsing 96%; this wild edge-to-edge action overshadowed a nearly flat S&P 500 (-0.19%), creating a stock-pickers' battlefield where sector rotation—healthcare +36% of gainers, industrials -35% of losers—mattered far more than macro direction.
30% Healthcare led a broad sector rebalancing, claiming over one-third of top gainers with names like YYGH (+63%, debt elimination), TNMG (+53%, delisting relief), and PRZO (+23%, first U.S. contract), while industrials bore the heaviest losses, suggesting money rotated defensively into biotech and specialty healthcare on mixed economic signals.
15% Five debutant names—SWVL, RR, JAB, PACB, HVIIR—returned after long absences, all landing in gainers, with SWVL's $13M funding round and PACB's inferred vaccine-sector tailwind signaling renewed retail interest in neglected equities amid the broader market calm.

Healthcare drove 36% of gainers 5 names returned after long absences PMI · 3-day gainers streak SWVL — first appearance RR — first appearance

Market Regime

Tue, Aug 25, 2026 Risk-On conf: medium macro · prototype

+28

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.5 p15 Drawdown-1.6% Held1d · nascent SinceAug 25

Top drivers: VIX percentile ▲ S&P 20d return ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Tue, Aug 25, 2026 13

S&P 500

7,677.28

−14.48

-0.19%

Dow Jones

53,577.40

+234.00

+0.44%

NASDAQ Composite

26,151.30

−138.41

-0.53%

NASDAQ 100

29,209.23

−281.73

-0.96%

DJ US Total Market

76,026.40

−191.28

-0.25%

Russell 1000

4,186.25

−6.47

-0.15%

S&P MidCap 400

3,799.77

−54.85

-1.42%

Russell 2000

3,010.02

−7.87

-0.26%

Russell 2500

1,283.50

+2.62

+0.20%

Russell 3000

4,370.88

−6.95

-0.16%

Nasdaq Financial-100

7,812.56

+68.26

+0.88%

NIFTY 50

24,334.55

+256.25

+1.06%

VIX

15.45

+0.56

+3.76%

Biggest Gainers

Tue, Aug 25, 2026 50

NCPL

Netcapital Inc.Financial Services

$0.57+$0.23

+87.2%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 87% jump in NCPL appears driven by technical factors, short squeeze activity, or undisclosed corporate events not yet reflected in major financial news feeds.

The absence of any headlines in the past two days makes it impossible to attribute this dramatic 87% gain to a specific announced catalyst such as earnings, regulatory approval, partnership, or guidance change. For a micro-cap stock like NCPL trading at $0.57, large single-day moves are not uncommon and can be triggered by several mechanisms: retail trading momentum or coordinated social media activity, short covering if the stock has meaningful short interest, low liquidity amplifying small buy volumes, or delayed disclosure of material news that has not yet been picked up by major news aggregators. Without evidence of a headline-driven event, the move likely reflects either technical/sentiment-driven trading or an information lag between the actual catalyst and public reporting.

YYGH

YY Group Holding Limited Class A Ordinary SharesIndustrials

$1.15+$0.73

+63.5%

NASDAQ · Mkt cap $4.5 M

YY Group announced elimination of $5.94 million in debt and cancellation of all outstanding warrants, reducing shareholder dilution and simplifying its capital structure, which likely drove the 63% gain.

The company's announcement to eliminate a secondary financing tranche and cancel 11,284 warrants represents a meaningful reduction in future dilution risk and financial obligations. This kind of capital structure simplification is typically viewed favorably by equity holders because it removes overhang from warrant conversion and reduces debt repayment pressure. The company retains only $1.37 million to repay by year-end, a much cleaner position. For a stock trading at $1.15 with historically volatile or distressed characteristics, this kind of de-risking move can trigger substantial repricing. The magnitude of the move suggests investors may have been concerned about dilution or debt burden, making the elimination of these obligations a significant positive catalyst.

ROC

ROC Energy Acquisition Corp.

$4.05+$1.54

+61.4%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 61% jump in ROC likely reflects either a delayed market reaction to a prior announcement, a technical or short-squeeze event, or undisclosed corporate development.

ROC Energy Acquisition Corp. is a SPAC, and the complete absence of recent news coverage despite a massive single-day gain is noteworthy. SPACs can experience sharp moves on several types of catalysts that may not always generate immediate Yahoo Finance RSS headlines: a merger agreement announcement, warrant exercises, shareholder meeting timing, or changes in deal terms. Additionally, SPACs with low trading volume and price near cash value can be susceptible to short squeezes or technical reversals. Without access to the company's filings or press releases directly, it is impossible to confirm whether an announcement was made but simply not indexed in the provided headlines, or whether this is a purely technical event. The 61% move is large enough to suggest a material corporate event rather than routine trading volatility.

ATXI

Avenue Therapeutics IncHealthcare

$0.40+$0.15

+60.0%

NASDAQ · Mkt cap $824 K

No news headlines were found in the last 48 hours, so the 60% gain on ATXI is unexplained by disclosed corporate developments. The move likely reflects technical trading, a delayed market reaction to earlier news, or unconfirmed rumors.

Avenue Therapeutics is a small-cap biopharmaceutical company, and the absence of any recent headlines combined with a substantial single-day gain suggests the move was not driven by a major announced catalyst. For biotech stocks at this market cap, such moves often result from technical factors like short covering or algorithmic trading in low-liquidity names, delayed reaction to earlier clinical or regulatory news not captured in the 48-hour window, or market chatter about pipeline progress that has not yet been formally disclosed. Without access to social media, research notes, or earnings release timing, we cannot determine which of these scenarios applies here. The rank as the fourth-biggest gainer suggests this was a notable move, but without corresponding news it remains speculative.

TNMG

TNL Mediagene Ordinary SharesCommunication Services

$0.57+$0.21

+53.1%

NASDAQ · Mkt cap $1.1 M

TNL Mediagene surged 53% after Nasdaq granted continued listing subject to meeting minimum bid price and stockholders' equity requirements by specified deadlines, signaling relief that the company avoided immediate delisting.

The headline establishes that Nasdaq has permitted TNL Mediagene to remain listed on condition of meeting two compliance milestones: a minimum bid price requirement by September 21, 2026 and a stockholders' equity requirement by October 30, 2026. This is a positive development for a stock trading at $0.57, as it removes the near-term threat of forced delisting. Investors may have interpreted the conditional approval as a stay of execution and a signal that the company has time to remediate its listing status, reducing existential risk. The 53% jump reflects relief buying rather than new business fundamentals; shareholders feared total loss through delisting, and the reprieve has value even if it only extends uncertainty by two months.

EXYN

Exyn Technologies, Inc.Technology

$3.21+$1.20

+52.6%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 52.63% gain likely reflects either delayed news dissemination, technical or options-driven momentum, or an untracked catalyst in the drone/robotics sector that EXYN operates in.

The absence of recent headlines despite a top-six daily gain suggests the catalyst either occurred outside Yahoo Finance's RSS feed window, was announced through channels not captured in this data source, or the move was driven by technical factors rather than fundamental news. EXYN operates in autonomous aerial systems and robotics, sectors that can be sensitive to contract announcements, funding rounds, or industry developments that may not immediately appear in mainstream financial headlines. Another possibility is that an announcement from yesterday or earlier is still driving algorithmic buying or short covering. Without access to company press releases, SEC filings, or broader financial news sources, attributing this move to a specific event would be speculation.

SWVL

Swvl Holdings Corp.

$2.22+$0.78

+51.3%

EONR.WT

EON Resources Inc WT

$0.10+$0.03

+50.1%

PMI

Picard Medical, Inc.Healthcare

$9.51+$2.78

+46.4%

NYSE · Mkt cap $6.8 M

Picard Medical shares surged 46.41% following a quarterly earnings beat announced on August 24, with revenue exceeding forecasts, driving strong investor enthusiasm.

The news clearly establishes that Picard Medical reported quarterly results that beat revenue expectations, triggering the 43-46% share price jump on the announcement date. The surge continued or solidified on August 25, ranking the stock among the day's top gainers. This is a classic earnings-driven catalyst where actual results exceeded consensus forecasts. The second headline about Philip Morris International and Altria appears to reference a different company (PM, a much larger tobacco conglomerate) and is not related to Picard Medical despite sharing the PMI ticker abbreviation in one headline. The earnings beat explanation directly accounts for the magnitude and timing of the move, with no contradictory evidence in the provided sources.

OFAL

OFA GroupIndustrials

$1.05+$0.34

+46.0%

ASPCR

A SPAC III Acquisition Corp.

$0.13+$0.04

+44.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 44% jump in this SPAC stock likely reflects either a technical or sentiment-driven move, possibly related to SPAC redemption dynamics or a delayed announcement not yet indexed by Yahoo Finance.

ASPCR is a blank-check acquisition company with a very low stock price of $0.13, typical of distressed or near-liquidation SPACs. The absence of any news in the 48-hour window before this jump makes it difficult to pinpoint a specific catalyst from reporting. SPACs in this price range often exhibit high volatility driven by redemption fears, potential merger announcements, or technical bounces off psychological support levels. The +44% move could reflect a rumored deal, a delayed press release not yet syndicated to major feeds, short-covering, or simply thin-liquidity dynamics common in penny-priced equities. Without corroborating headlines, attribution remains speculative.

DAIC

CID HoldCo, Inc.Technology

$3.86+$1.73

+44.1%

NASDAQ · Mkt cap $508 K

No news headlines were found in the last 48 hours, so the 44% gain on DAIC cannot be attributed to a disclosed corporate event; the driver remains unknown without additional information.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot point to an earnings announcement, regulatory action, M&A news, or guidance change as the catalyst for this substantial move. DAIC is a blank-check holding company, which historically can be subject to rapid repricing on speculation, technical flows, or information not yet reflected in major news wires. Possible categories of explanation include a pending announcement not yet widely syndicated, short covering or retail activity, options expiry dynamics, or delayed cross-listing or merger developments—but these remain unconfirmed hypotheses. Without concurrent news or detailed order-flow data, the specific trigger cannot be determined from the evidence at hand.

SKYH.WT

Sky Harbour Group Corporation

$0.38+$0.11

+38.7%

XPON

Expion360 Inc.Industrials

$5.30+$1.82

+35.1%

NASDAQ · Mkt cap $3.6 M

Expion Energy closed a $9 million private placement and announced a strategic pivot into Louisiana oil and gas assets with CEO transition, combined with potential for an additional $91 million in funding, driving investor confidence in the company's new energy strategy.

The 35% gain aligns directly with multiple bullish announcements released on August 24. The company closed the initial tranche of a $9 million private placement with the same investor group signaling willingness to commit up to an additional $91 million, demonstrating strong institutional backing. Simultaneously, Expion announced acquisition of Louisiana oil and gas assets and repositioned itself to supply natural gas to AI data centers and LNG export markets, representing a material business pivot from its prior focus. A new CEO with owner-operator experience was also appointed, suggesting management credibility in executing this strategy. The combination of near-term capital secured, significant upside funding potential, a defined acquisition, market tailwinds from AI infrastructure demand, and experienced leadership provides multiple reasons for algorithmic and retail enthusiasm on the same trading day.

BRNX

Brenx Ltd.

$5.55+$1.41

+33.9%

ZSTK

ZeroStack Corp.Financial Services

$6.54+$1.58

+33.1%

NASDAQ · Mkt cap $32 M

ZeroStack's cryptocurrency holdings surpassed $1 billion on the day of the 33% jump, likely driving investor enthusiasm for the company's crypto exposure in a favorable market environment.

The headline announcing ZeroStack's crypto holdings reaching $1.06 billion was published at 14:03 UTC on 2026-08-25, the same day the stock jumped 33%. This timing aligns with the price move. The development suggests the company has built substantial value in digital assets, which appeals to investors betting on cryptocurrency appreciation and to those viewing ZeroStack as a leveraged play on crypto market strength. Without additional context on whether this milestone was a surprise versus previously disclosed guidance, or whether it reflects a large acquisition versus organic accumulation, the exact mechanism is somewhat unclear. However, the correlation between milestone announcement and sharp upside move is direct enough to anchor the explanation.

FSHPR

Flag Ship Acquisition Corporation

$0.09+$0.02

+28.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 28.57% gain on FSHPR cannot be attributed to a reported event. The move likely reflects either technical trading activity, delayed news dissemination, or market speculation common in blank-check acquisition vehicles.

Flag Ship Acquisition Corporation is a SPAC (Special Purpose Acquisition Company), a shell entity formed to merge with or acquire a private company and take it public. With no recent news available through the provided RSS feed, the price jump cannot be directly attributed to an earnings report, merger announcement, regulatory decision, or guidance change. SPACs are known for volatile trading around merger announcements, shareholder votes, or deadline-driven events. The 28.57% move on such a low absolute price ($0.09) could reflect intraday technical trading, options-driven activity, or speculation ahead of an announcement. Without access to real-time news or company filings, it is impossible to determine whether there was a material corporate development that occurred outside the RSS feed window or whether this is purely momentum-driven trading.

ACTU

Actuate Therapeutics, Inc.Healthcare

$1.57+$0.34

+27.6%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 27.64% gain likely reflects either a delayed market reaction to an earlier announcement, a technical/short-covering event, or an unreported development. The actual catalyst remains unclear from available public information.

A small-cap biotech stock gaining 27.64% without corresponding news in the trailing 48 hours suggests either a lag between an event and headline indexing, or a catalyst not yet picked up by major financial news feeds. Actuate Therapeutics is a clinical-stage biotech company, and this class of stock typically moves sharply on clinical trial results, regulatory decisions (FDA feedback letters, breakthrough designations), partnership announcements, or capital raise news. Given the magnitude of the move and the lack of recent headlines, this could represent short covering in a thinly traded name, a technical breakout, or reaction to news that has not yet been widely disseminated. Without access to press releases, company filings, or real-time trading data, determining which scenario applies is not possible from the information provided.

USDEW

StablecoinX Inc. Warrants

$1.34+$0.28

+26.4%

TENX

Tenax Therapeutics IncHealthcare

$2.32+$0.48

+25.9%

NASDAQ · Mkt cap $71 M

No news headlines were found in the last 48 hours for TENX, so the 25.92% jump cannot be attributed to a specific disclosed catalyst. The gain likely stems from technical trading, delayed news, or a rumor not yet reflected in mainstream headlines.

Without recent headline support, attributing the move to a concrete event is impossible based on the provided data. Tenax Therapeutics is a clinical-stage biopharmaceutical company, so catalysts typically include clinical trial results, regulatory decisions, partnership announcements, or funding news. Small-cap biotech stocks are also highly susceptible to short covering, technical rebounds after downtrends, or retail attention. The absence of news in the Yahoo Finance RSS over the past 48 hours does not rule out an announcement being made earlier or on a separate channel, nor does it rule out intraday rumors or social media activity driving the move. Given the 25.92% gain and the company's sector, this could reflect either positive development news not yet syndicated to major feeds, or momentum-driven trading in a illiquid stock.

BSAAR

BEST SPAC I Acquisition Corp. Rights

$0.10+$0.02

+25.4%

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$3.75+$0.72

+23.7%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours for LHSW, so the 23.68% gain likely reflects a technical rebound, delayed news pickup, or retail trading interest unconnected to fresh corporate developments.

The absence of recent news headlines is notable given LHSW's ranking as the 22nd biggest gainer on the day. This disconnect suggests the move was not driven by a major announced corporate event, earnings release, regulatory action, or strategic announcement. For a smaller-cap international group stock trading on NASDAQ, price swings of this magnitude without accompanying headlines could reflect several categories of activity: technical bounce-back from recent selling pressure, short-covering in a thinly traded name, retail or algorithmic trading patterns responding to relative strength indicators, or delayed market digestion of news that may have been released before the Yahoo Finance RSS snapshot window. Without access to intraday data, trading volume analysis, or earlier news cycles, attribution remains speculative. The lack of a clear catalyst from the information provided limits confidence in explaining the specific cause.

EXOD

EXODUS MOVEMENT INC.Technology

$9.56+$1.81

+23.4%

NYSE · Mkt cap $220 M

No news headlines were found in the last 48 hours for EXODUS MOVEMENT INC., so the 23.35% rally likely stems from technical factors, delayed news propagation, or untracked catalysts.

The absence of any Yahoo Finance headlines in the past 48 hours makes it impossible to anchor the move to a specific corporate event such as earnings, guidance, a partnership, or regulatory approval. A 23.35% single-day jump for a stock trading near $10 could reflect several scenarios: a technical bounce after oversold conditions, retail or institutional accumulation driven by social media or internal messaging not yet reflected in mainstream financial RSS feeds, a delayed market reaction to an announcement published outside the tracked window, short covering, or volatility in a thinly traded security. Without access to press releases, SEC filings, or real-time transaction data, the actual catalyst remains unknown. For a micro-cap stock like EXODUS MOVEMENT INC., moves of this magnitude are not uncommon but typically require either concrete news or evidence of unusual trading volume to be explained.

CRML

Critical Metals Corp.Basic Materials

$8.09+$1.57

+23.2%

NASDAQ · Mkt cap $965 M

Critical Metals surged 23% on August 25 with no official company announcement; trader speculation about a European lithium merger is circulating but remains unverified and the actual catalyst remains unclear.

The headlines establish that CRML jumped roughly 20-23% on August 25 with no official press release or earnings announcement to explain the move. One article explicitly notes the jump lacks a company announcement while mentioning an unverified European lithium merger rumor circulating in trader circles, though this rumor is not substantiated by any named source or formal disclosure. The stock had declined 6.19% the prior day and 43.19% over three months, so the move represents a sharp reversal. A second headline references fresh attention after recent weakness but provides no specific catalyst. As a rare earth and critical metals company, CRML typically responds to commodity price moves, geopolitical supply news, government funding announcements (like the $1.55B program mentioned for competitors), or M&A activity, but none of these are confirmed in the available headlines. The mention of unverified rumors is a red flag that the spike may be speculative or based on social media chatter rather than material fact.

PRZO

ParaZero Technologies Ltd. - Ordinary SharesIndustrials

$0.82+$0.15

+23.0%

NASDAQ · Mkt cap $16 M

ParaZero secured its first DefendAir order from a U.S. federal agency for counter-UAS systems, marking entry into the U.S. market and validating commercial demand for its defensive drone technology.

The company announced today that it received its initial DefendAir order from a U.S. federal agency, which includes net launchers, Net Pods, and on-site operator training. This represents a material inflection point for ParaZero: it demonstrates proof of concept in the U.S. counter-UAS market, validates the DefendAir product line as commercially viable, and opens a potentially large addressable market with government customers. For a smaller aerospace and defense technology firm trading at $0.82, a first significant government contract from a U.S. agency—particularly one involving training and full system deployment—typically signals revenue generation ahead and de-risks the business model. The 23% single-day gain reflects investor recognition that the company has transitioned from development to revenue-generating customer traction.

CAPR

Capricor Therapeutics IncHealthcare

$8.30+$1.52

+22.3%

NASDAQ · Mkt cap $464 M

Capricor's stock jumped 22% after the FDA extended its review of the Deramiocel DMD treatment by three months to November 22, which investors interpreted as a positive signal despite analyst concerns about rejection risk.

On August 24, Capricor announced that the FDA pushed back its decision deadline for Deramiocel from August 22 to November 22, 2026. The extension followed submission of additional Phase 3 HOPE-3 data with a refined proposed indication. Market reaction was notably positive despite HC Wainwright maintaining a Neutral rating and flagging high rejection risk. The extension itself is ambiguous: it could signal FDA receptiveness to the new data package and refined indication, or it could indicate unresolved safety or efficacy concerns requiring more time. Investors appear to have chosen the optimistic interpretation, treating the extension as a reprieve and implicit encouragement rather than a warning sign. The timing of the news release on Monday August 24 aligns precisely with the day's strong move, making causation reasonably direct.

RZLV

Rezolve AI LimitedTechnology

$2.97+$0.53

+21.8%

NASDAQ · Mkt cap $1.2 B

Google selected Rezolve AI's distributed database technology for Google Cloud Web3 operations, marking the company's first major commercial deployment and validating its AI data infrastructure strategy targeting a $295 billion market by 2030.

Multiple news sources confirm that on August 25, 2026, Google announced it selected Rezolve AI's proprietary distributed database platform for handling indexing and data pipelines within Google Cloud Web3's blockchain datasets. This represents a significant validation milestone for an AI infrastructure startup, as deployment by a hyperscaler like Google typically signals both technical credibility and substantial revenue potential. The headlines describe this as the platform's first major commercial deployment, which would naturally attract investor interest in an early-stage AI infrastructure company. The framing around a $295 billion market opportunity through 2030 further supports investor enthusiasm about the addressable market size. The 21.77% single-day gain and ranking as the 27th largest gainer suggest the market interpreted this as materially positive news for the company's commercialization trajectory.

Richtech Robotics Inc.

$1.98+$0.35

+21.5%

RBOT

D8 Holdings Corp.Healthcare

$0.04+$0.01

+21.2%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours, so the 21% gain on RBOT is unexplained by recent public announcements; the move may reflect technical trading, short covering, or undisclosed catalysts.

RBOT (D8 Holdings Corp.) jumped 21% on August 25, 2026, but zero financial news was reported in the prior 48 hours on Yahoo Finance. This disconnect makes root cause analysis difficult. For a micro-cap trading at $0.04, typical catalysts include retail momentum or short squeezes on low float, technical breakouts triggering stop-loss runs, delayed press releases not yet syndicated to major feeds, or rumors on social media or chat forums that precede formal news. Without access to SEC filings, insider transactions, or social sentiment data, identifying the specific trigger is speculative. The absence of earnings, guidance, partnership, or regulatory announcements in the headline feed means the move is either driven by non-news factors or by news that has not yet propagated to the RSS feed checked.

IFRX

InflaRx NVHealthcare

$2.45+$0.42

+20.7%

NASDAQ · Mkt cap $321 M

No news was reported in the last 48 hours, so the 20.69% gain likely stems from technical trading, a delayed market reaction to an older announcement, or intraday momentum in a lower-volume biotech stock.

InflaRx is a small-cap biopharmaceutical company, and the absence of any headlines in the last two days makes it impossible to anchor the move to a specific corporate event like clinical trial results, FDA decisions, or partnership announcements. Biotech stocks of this size can experience sharp intraday swings from several sources: short-covering in thinly traded names, algorithmic momentum chasing after a prior-day catalyst that wasn't captured in the news feed, or delayed market processing of an older press release. Without access to trading volume, short interest, or earlier headlines, we cannot distinguish between these scenarios. It is also possible that news appeared outside the Yahoo Finance RSS feed captured here.

JAB

JAB Acquisition Corp I

$9.96+$2.05

+20.6%

XRTX

XORTX Therapeutics Inc.Healthcare

$2.26+$0.39

+20.5%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours for XRTX, so the 20.53% gain likely stems from a technical bounce, delayed news pickup, or sector-wide movement rather than a company-specific announcement.

XORTX Therapeutics is a clinical-stage biopharmaceutical company focused on rare kidney disease treatments. Without recent headlines, the sharp one-day jump cannot be attributed to earnings, clinical trial results, FDA decisions, or partnership announcements based on available information. For small-cap biotech stocks like XRTX, typical catalysts include positive Phase trial data releases, regulatory approvals, or financing news—all of which would normally generate headlines within 48 hours if they occurred. The absence of news combined with the sizable gain suggests either a technical rebound after oversold conditions, a short covering event if the stock has significant short interest, delayed social media or investor discussion that hadn't yet reached mainstream financial media, or possibly sector momentum in biotech names more broadly on the snapshot date.

BOXL

Boxlight CorpTechnology

$6.62+$1.12

+20.4%

NASDAQ · Mkt cap $3.5 M

Boxlight announced Composer, a new platform for simplifying education technology design and deployment, on the morning of the 20% rally, making this the most direct catalyst for the stock's jump.

On August 25, 2026, Boxlight Corporation announced the launch of Boxlight Composer, described as a solution to simplify and scale the design and deployment of education technology solutions. The announcement was made during market hours (13:11 UTC) on the same day as the 20.36% gain, establishing a clear temporal link between the news and the price action. The company framed Composer as a product addressing a market need in education technology implementation and deployment. For an education technology vendor like Boxlight, a new platform launch that promises to expand addressable market or improve competitive positioning can justify significant intraday upside, particularly if investors view it as a meaningful revenue driver or margin improvement opportunity. However, the provided headline text is incomplete, so the full scope of the announcement, any financial metrics, or market commentary are not available for evaluation.

CELG.RI

Bristol-Myers Squibb Company Ce

$0.12+$0.02

+20.1%

FLYX.WT

flyExclusive, Inc.

$0.18+$0.03

+20.1%

TMCR

The Metals Royalty Company Inc.Basic Materials

$6.38+$1.05

+19.5%

NASDAQ · Mkt cap $396 M

TMCR jumped 19.48% on news that the company closed an additional 1.0% Mesabi royalty acquisition and secured $165 million in financing, both announced on August 24, 2026.

The Metals Royalty Company announced on August 24 the completion of two major transactions: acquisition of an additional 1.0% stake in the Mesabi royalty and the closing of a $165 million financing round. These are material corporate actions that directly expand the company's asset base and strengthen its balance sheet. For a royalty company focused on advancing U.S. critical mineral security, adding royalty exposure and securing substantial capital are positive catalysts that justify investor enthusiasm. The stock's rank as the 36th biggest gainer suggests the market viewed this transaction positively relative to sector peers. The timing of the news release on August 24 directly precedes the August 25 trading day, establishing clear causality.

OESX

Orion Energy Systems IncIndustrials

$24.91+$3.98

+19.0%

NASDAQ · Mkt cap $76 M

No news headlines were found in the last 48 hours, so the 19% gain on OESX likely stems from technical factors, delayed news pickup, or market sentiment unrelated to publicly reported corporate events.

The absence of any headlines in the last 48 hours makes it difficult to pinpoint a specific corporate catalyst. OESX is a small-cap clean energy and lighting technology company, a sector that can experience volatility from broad market moves, short covering, or retail investor interest. The stock ranks 37th in daily gainers, suggesting it caught momentum. Possible explanations include a delayed earnings release or guidance announcement that has not yet appeared in the Yahoo Finance feed, short-squeeze activity given the stock's typical trading pattern, or a sector-wide rally in renewable energy or energy efficiency stocks. Without headline confirmation, however, we cannot establish a definitive cause and must acknowledge the move remains unexplained by available news data.

NBRGR

Newbridge Acquisition Limited Rights

$0.22+$0.03

+18.9%

NASDAQ

No news was published in the last 48 hours, so the 18.85% gain cannot be attributed to any identifiable headline-driven catalyst. The move is likely driven by technical factors, delayed news dissemination, or trading activity typical of low-liquidity SPAC-related securities.

Yahoo Finance returned no headlines for NBRGR in the past 48 hours, which means we cannot ground the price move in any specific corporate event, earnings announcement, regulatory action, or strategic development. This is notable because a nearly 19% single-day gain for a stock trading at $0.22 would typically warrant news coverage if it were fundamentally driven. NBRGR is a Newbridge acquisition rights security, a SPAC-related instrument that can be sensitive to shifts in SPAC sentiment, changes in the underlying deal status, or redemption dynamics. Rights offerings can experience outsized percentage moves on relatively modest trading volume. Without access to the actual order flow or deal status, we cannot determine whether this move reflects legitimate new information about the acquisition, technical rebalancing, short covering, or simply the normal volatility of thinly traded micro-cap securities.

PACB

Pacific Biosciences of California IncHealthcare

$1.52+$0.24

+18.8%

NASDAQ · Mkt cap $472 M

PACB likely rallied on sector enthusiasm following the Merck-Moderna cancer vaccine breakthrough announced on August 25th, as sequencing and diagnostic tools are critical to vaccine development and manufacturing.

The headline "Cancer Vaccine Breakthrough Lifts 5 Biotech Names" published on August 25th at 11:15 UTC, the same day PACB gained 18.75%, suggests the stock benefited from positive sentiment in the biotech space tied to the Merck-Moderna cancer vaccine success. The article explicitly states that five companies "stand to collect a toll on every single dose manufactured," indicating supply chain and enabling technology plays are being identified as beneficiaries. Pacific Biosciences manufactures long-read DNA sequencing instruments used in genomic research, vaccine development, and quality control—making it plausibly relevant to vaccine manufacturing pipelines. However, the headline does not name PACB specifically, so the exact mechanism of how the stock was included in analysts' coverage is not confirmed by the evidence provided. The August 24th healthcare tailwinds headline offers only general sector color and does not explain the specific timing or magnitude of today's move.

RAIN

Rain Therapeutics Inc.Industrials

$1.15+$0.18

+18.6%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 18.62% gain likely reflects either a delayed market reaction to an earlier announcement, short covering, or technical trading activity typical of small-cap biotech stocks.

Rain Therapeutics is a small-cap biotech company with a history of volatility. The absence of recent news headlines does not rule out a catalyst; the news feed provided may simply be incomplete or the stock price move could be responding to information that has not yet propagated to the Yahoo Finance RSS feed. Alternatively, this type of gain is common in small-cap therapeutics stocks during periods of short covering or technical momentum, where low float and trading volume can amplify percentage moves on modest absolute dollar inflows. Without confirmed news, the move could also reflect regulatory developments, clinical trial updates, partnership announcements, or insider activity that has not yet been widely reported. Biotech investors should verify directly with the company or SEC filings whether any material announcements were made just outside the 48-hour window.

HVIIR

Hennessy Capital Investment Corp. VII Rights

$0.32+$0.05

+18.5%

ADVB

Advanced Biomed Inc. Common StockHealthcare

$9.37+$1.46

+18.5%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours for ADVB, so the 18.46% gain likely reflects a delayed market reaction to an earlier announcement, technical/short-covering activity, or an untracked news event.

The absence of recent headlines despite an 18.46% single-day jump is notable for a biomedical company. Possible explanations include a delayed market reaction to news from earlier in the week that has not yet cycled into the Yahoo Finance RSS feed, short-covering or technical buying in a thinly traded security, internal news flow from company channels not yet reflected in aggregated headlines, or an unconfirmed rumor circulating among retail investors. Biomedical stocks in particular respond sharply to clinical trial outcomes, regulatory approvals, partnership announcements, or analyst upgrades. Without access to the news itself, we cannot distinguish between these scenarios. The timing gap between the move and the news search suggests either a lag in media aggregation or that the catalyst originated elsewhere.

ABCL

AbCellera Biologics IncHealthcare

$12.50+$1.89

+17.8%

DFNS

Defense Industries International IncIndustrials

$13.07+$1.97

+17.7%

NYSE · Mkt cap $27 M

Noble Financial initiated a Buy rating on T3 Defense with a $30 price target on August 25, triggering a 17.75% gain; the stock surged 64.3% in pre-market trading on the analyst upgrade.

The headline directly attributes the stock's move to a single catalyst: Noble Financial's initiation of coverage with a Buy rating and a price target of $30, which represents significant upside from the current $13.07 price. This type of analyst action—a reputable firm going bullish on a defense technology company with a material price target—typically drives immediate buying pressure, particularly in pre-market trading when volume is lighter and moves can be amplified. The magnitude of the move (17.75% at the daily close, following a 64.3% pre-market surge) is consistent with the strength of a fresh Buy rating in the defense sector, where geopolitical and procurement cycles often attract institutional attention. No earnings, contract wins, or other company-specific news is mentioned in the headline, so the driver is purely the analyst sentiment shift.

RPGL

Republic Power Group LimitedTechnology

$1.94+$0.31

+17.7%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours for RPGL, so the 17.69% gain likely reflects either a delayed market reaction to an earlier announcement, technical buying, or a catalyst not yet indexed by major news feeds.

Yahoo Finance returned zero headlines for Republic Power Group Limited in the past 48 hours, which means we cannot anchor the move to a specific corporate event like earnings, guidance, M&A activity, or regulatory approval. The stock ranked 45th among daily gainers, suggesting genuine volume and interest rather than a micro-cap spike. Possible explanations within reasonable inference: first, a material announcement may have been released after the news feed cutoff or by a channel not yet syndicated to Yahoo; second, the stock could be responding to sector momentum in renewable or utility infrastructure if Republic Power Group operates in that space; third, technical factors such as short covering or options expiry mechanics could drive a sharp single-day move in a lower-priced stock. Without knowing RPGL's market cap, insider holding structure, or short interest, we cannot assess a squeeze scenario. The lack of news coverage remains the dominant constraint on explanation.

HAO

Invesco China Small Cap ETFCommunication Services

$3.49+$0.52

+17.5%

NASDAQ · Mkt cap $1.4 M

No news headlines were found in the last 48 hours, so the 17.51% jump in HAO likely reflects either a broad market rally in Chinese equities, technical/sentiment reversal, or an unreported corporate development affecting the underlying holdings.

HAO is an ETF tracking Chinese small-cap stocks, so its daily moves typically reflect broad sector performance rather than company-specific events. The absence of news headlines in the last 48 hours means we cannot tie this gain to a specific catalyst like earnings, regulatory action, or geopolitical news. Given that HAO offers exposure to Chinese small-cap equities, the move could reflect a rebound in Chinese equity sentiment, strength in the yuan, or positive macroeconomic data from China that has not yet surfaced in the news search. Alternatively, this could be a technical bounce after prior weakness, or a delayed market reaction to announcements that occurred outside the headline window. Without confirmed reporting, the specific catalyst remains unknown.

INBX

Inhibrx, Inc.

$123.26+$18.23

+17.4%

GOSS

Gossamer Bio IncHealthcare

$0.21+$0.03

+16.6%

NASDAQ · Mkt cap $77 M

Gossamer Bio announced a $250 million funding round on August 24 to advance seralutinib's clinical development, which likely triggered the 16.58% stock price gain the following trading day.

The headline is directly dated August 24 and describes a substantial $250 million capital raise earmarked for advancing seralutinib, the company's lead clinical asset. For a small-cap biotech firm trading at $0.21 per share, securing a quarter-billion dollars in funding is a material positive catalyst that reduces dilution risk, extends cash runway, and signals investor confidence in the program. The timing aligns closely with the August 25 price jump, making this the most plausible explanation for the move. No offsetting negative news or contradictory information appears in the provided headlines. The stock's ranking as the 48th biggest gainer suggests this was a notable intraday response, consistent with the announcement's significance to the company's financing profile.

STDN

Standard Nuclear, Inc.Basic Materials

$13.91+$1.96

+16.4%

NYSE · Mkt cap $2.4 B

No relevant news headlines were found in the last 48 hours, so the 16.36% gain on Standard Nuclear likely reflects sector momentum, technical buying, or an undisclosed catalyst not yet picked up by major news feeds.

Standard Nuclear is a nuclear energy development company, and the absence of headlines in the RSS feed does not rule out a real catalyst. The nuclear sector has experienced significant investor interest in 2026 due to AI demand for power and policy support for clean energy. The stock's substantial single-day gain could stem from several sources: a company-specific announcement released through channels not yet indexed by Yahoo Finance RSS, positive commentary on the nuclear sector from a major institution or analyst, short-covering in a name with limited float, or overnight international news affecting the space. Without access to company filings, press releases, or real-time social media signals, attribution remains speculative. The timing and magnitude of the move suggest something material rather than random drift, but the lack of corroborating headlines limits confidence in pinpointing the cause.

APRE

Aprea Therapeutics Inc

$0.93+$0.13

+16.2%

Biggest Losers

Tue, Aug 25, 2026 50

GPAC

Global Partner Acquisition Corp IIFinancial Services

$0.41−$9.64

-96.0%

NASDAQ · Mkt cap $295 M

No news headlines were found in the last 48 hours, but a 96% single-day collapse in a SPAC suggests either a merger deal failure, redemption trigger, or delisting warning announcement that may not yet be indexed by Yahoo Finance.

Global Partner Acquisition Corp II is a special purpose acquisition company, and SPACs are uniquely vulnerable to catastrophic single-day moves tied to specific corporate events: merger termination, shareholder redemption thresholds being breached, or regulatory delisting notices. The absence of news in the Yahoo Finance feed does not rule out that a material announcement was made; it may simply indicate a lag in syndication or that the news broke outside the RSS indexing window. A 96% decline is almost never driven by market sentiment alone—it typically reflects a binary event such as deal closure failure, a covenant breach triggering forced liquidation, or notification of imminent delisting. Without access to the company's investor relations announcements or SEC filings from the snapshot date, the precise catalyst cannot be confirmed, but the magnitude strongly suggests a concrete corporate action rather than technical selling or rumor.

UGRO

URBAN-GRO INC.Industrials

$0.10−$0.12

-56.5%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours to explain UGRO's 56.52% single-day collapse to $0.10, suggesting either a delayed market reaction to an earlier event or a catalyst not yet picked up by major financial feeds.

The absence of recent news coverage for a stock experiencing a nearly 57% loss is unusual and raises questions about the cause. For a microcap stock like UGRO trading at $0.10, potential drivers of this magnitude of decline typically include significant earnings misses, cash burn warnings, dilutive financing announcements, regulatory setbacks, or news of insider selling. The stock's ultra-low price suggests it may already be distressed, making it vulnerable to technical cascades or margin calls if holders face liquidity pressures. Without headlines from the last 48 hours, the move may reflect a delayed market reaction to news released earlier, a private development not yet covered by financial news aggregators, or deteriorating market conditions for the sector. Agricultural technology or indoor farming stocks have faced cyclical headwinds and venture capital pullback in recent years, which could be relevant context.

ZVZZT

$14.05−$16.95

-54.7%

OSRH

Bellevue Life Sciences Acquisition Corp.Healthcare

$0.11−$0.14

-54.6%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, making it impossible to identify a specific catalyst for the 54.61% collapse in OSRH. The sharp drop is likely driven by either a delayed market reaction to an earlier announcement, technical selling pressure, or a development not yet captured in…

OSRH is a blank-check acquisition company, a structure known for high volatility and sensitivity to deal progress, redemptions, or sponsor activity. With no recent headlines available, the massive single-day decline could reflect several typical triggers for SPACs: news of deal termination or delay announced yesterday that has not yet appeared in the RSS feed lag, shareholder redemption pressure or management updates released outside standard news channels, technical capitulation following a period of weakness, or deterioration in the underlying target company's prospects if a merger is in advanced stages. The 54% loss in one day on a stock already trading below $1 suggests either a fundamental event or extreme technical breakdown in a highly volatile microcap security.

BLAC

Bellevue Life Sciences Acquisition Corp. - Common Stock

$0.12−$0.13

-53.4%

FVN

Future Vision II Acquisition Corporation Ordinary sharesFinancial Services

$9.20−$8.83

-48.7%

NASDAQ · Mkt cap $88 M

No news headlines were found in the last 48 hours, so the 48.7% drop cannot be attributed to a disclosed event; the likely cause involves a SPAC-related redemption, liquidation event, or delisting announcement that may not yet appear in news feeds.

Future Vision II Acquisition Corporation is a SPAC, a special purpose acquisition vehicle designed to merge with an operating company. The magnitude of the decline (nearly 49%) combined with the complete absence of news in the last 48 hours suggests either a redemption deadline has passed, a merger deal has fallen apart, or a delisting notice has been issued. SPACs often experience sharp drops when they fail to complete a merger within their charter deadline, when shareholders redeem shares en masse ahead of a deal vote, or when insiders announce the vehicle will liquidate. The stock trading at $9.20 near the original $10 SPAC issuance price is consistent with a post-redemption residual holder situation. Without headline confirmation, this remains inference based on the SPAC structure rather than reported fact.

AMIX

Autonomix Medical, Inc. Common StockHealthcare

$7.21−$4.35

-37.3%

NASDAQ · Mkt cap $5.7 M

Autonomix Medical announced a $4.9 million warrant inducement priced at a premium to market, which typically signals dilution concerns and triggered a sharp 37% sell-off on the same trading day.

The company's warrant inducement announcement on August 24-25, 2026 appears to be the proximate cause of the steep decline. When a company issues new warrants at prices above the current market rate, it often signals financial stress or a need for capital and raises shareholder dilution concerns. The timing of the announcement coinciding with the stock's placement as the seventh biggest loser suggests investors reacted negatively to this capital structure move. The warrant inducement under Nasdaq rules indicates the company sought to incentivize existing warrant holders to exchange or exercise their holdings, a tactic typically employed when management believes the current warrant terms are unfavorable or the company needs liquidity. Absent additional context about the company's cash position or strategic rationale, the market has penalized the stock sharply, interpreting the move as dilutive and potentially indicative of financial pressure.

FLZH

Flash Sports & Media Holdings, Inc.Communication Services

$0.10−$0.07

-35.7%

NASDAQ · Mkt cap $60 M

No news headlines were found in the last 48 hours to explain the 35.66% drop in FLZH stock, making the specific catalyst unclear without additional information.

The absence of any recent news headlines coinciding with a significant single-day loss makes it difficult to pinpoint a definitive cause. However, micro-cap and penny stocks like FLZH, trading at $0.10, are typically subject to several common catalyst categories: delayed disclosure of prior announcements (earnings misses, insider selling, or regulatory filings that markets are only now fully pricing in), technical liquidation or forced selling due to margin calls or stop losses, unconfirmed rumors or social media activity that drive retail interest, or changes in listing compliance status. Given FLZH's position as the eighth biggest loser on a given day without corresponding headlines, this could also reflect broader sector weakness in sports and media, or a delayed market reaction to information that broke just outside the 48-hour window. Without access to intraday events, regulatory filings, or trading data, the true driver remains speculative.

RCON

Recon Technology LtdEnergy

$2.03−$0.89

-31.2%

NASDAQ · Mkt cap $1.7 M

Recon Technology announced winning a RMB 9.6 million oilfield digitalization project on the morning of the 31% drop, suggesting the market viewed the contract as insufficient to justify current valuation or as disappointing relative to expectations.

The company issued not one but two nearly identical press releases within three hours on August 25 announcing the same RMB 9.6 million oilfield project win. This is unusual promotional activity that might indicate management was attempting to support the stock price. The contract itself—approximately US$1.3 million equivalent based on the partial headline—is a legitimate business development win for a China-based oilfield services provider. However, a 31% single-day collapse despite positive news suggests either the market has lost confidence in the company's ability to execute or grow meaningfully, the contract was already priced in and disappointed investors expecting something larger, or the stock was subject to a technical or sentiment reversal unrelated to this specific announcement. The timing of the announcement coinciding with the drop is notable but the causation remains unclear—the news may have triggered selling rather than buying.

FBDT

First Breach Inc.

$1.43−$0.67

-30.9%

DKS

Dick's Sporting Goods IncConsumer Cyclical

$124.40−$55.10

-30.7%

NYSE · Mkt cap $13 B

Dick's Sporting Goods reported worse-than-expected Q2 earnings, missed sales forecasts, and slashed full-year guidance citing weakness at its Foot Locker acquisition and industry-wide promotional pressure, triggering its worst single-day stock decline on record.

The headlines establish a clear consensus around Dick's earnings announcement on August 25, 2026. The company delivered 4.9% comparable store sales growth but consolidated EPS fell to $3.53, missing expectations. More critically, management cut full-year sales and profit forecasts, citing rising inventory levels forcing heavy promotional discounting across the industry and operational challenges at the recently acquired Foot Locker unit. The 30.7% single-day decline reflects both the magnitude of the guidance cut and investor concerns about consumer demand and competitive pressure in sporting goods retail. The selloff was severe enough to depress related stocks, particularly footwear brands like Nike and Genesco, which depend on Dick's as a distribution partner.

SLQT

Selectquote IncFinancial Services

$0.55−$0.24

-30.6%

NYSE · Mkt cap $133 M

SelectQuote reported a Q4 revenue miss and issued weak fiscal 2027 guidance focused on cost cuts, triggering a sharp 30% sell-off as investors repriced expectations for growth and profitability.

SelectQuote released fourth quarter fiscal 2026 earnings on August 25, 2026, and the market reaction was decisively negative. While the company did report revenue growth and improved profitability for the year, it missed on Q4 revenue relative to expectations. More importantly, management's fiscal 2027 outlook emphasized cost efficiency and cost-cutting measures rather than revenue expansion or margin acceleration, signaling a potential slowdown ahead. The combination of a near-term miss and a cautious forward guidance prompted rapid institutional and retail selling, placing SLQT among the day's twelve biggest losers. The 30% single-day decline reflects the market's disappointment with both the quarterly result and the company's strategic pivot toward defensive cost management.

SHMD

SCHMID Group N.V.Industrials

$3.42−$1.45

-29.8%

NASDAQ · Mkt cap $343 M

SCHMID Group reported H1 2026 results with revenue growth but sharply reduced its full-year 2026 margin guidance due to weaker-than-expected gross margins and lower-margin revenue mix, triggering the 29.78% sell-off.

The three consecutive news releases on August 25th all converge on the same negative catalyst: while SCHMID maintained its revenue target above €100 million, management cut profitability guidance for the full year after delivering lower gross margins in the first half and acknowledging that a larger portion of revenue came from lower-margin business segments. The earnings call highlights and formal guidance update both emphasize this margin pressure despite citing positive factors like accelerating order intake and ongoing cost reductions. This is a classic "revenue miss turns into earnings miss" scenario where top-line growth is offset by margin deterioration, causing investors to re-rate the stock downward on lower expected profitability. The magnitude of the decline suggests the margin guidance cut was substantial enough to materially reduce full-year earnings expectations.

GIPR

Generation Income Properties Inc.Real Estate

$0.54−$0.21

-27.4%

NASDAQ · Mkt cap $253 K

Generation Income Properties announced asset sales to reduce preferred equity debt by $4 million, signaling ongoing financial stress and deleveraging pressure that likely triggered the sharp 27% drop in share price.

The headline establishes that GIPR sold non-core properties and is using proceeds to redeem Loci Capital preferred equity. On its face, debt reduction is typically viewed as positive, but the market reaction suggests investors interpreted this as a forced deleveraging move rather than a strategic refinancing. The sale of non-core assets and emphasis on debt reduction imply the company may be under financial pressure or covenant constraints, which can signal weakness to equity holders who sit below preferred equity in the capital structure. The stock's position as the 14th biggest loser today confirms this was market-wide negative sentiment toward the announcement, not a technical blip. Without additional context on the company's liquidity position, asset quality, or preferred terms, we cannot rule out that the sales indicate deeper operational or cash flow challenges, which would explain the magnitude of the decline.

ZEO

ESGEN Acquisition Corporation

$0.29−$0.10

-25.9%

BRLS

Borealis Foods IncConsumer Defensive

$1.31−$0.46

-25.9%

NASDAQ · Mkt cap $19 M

No news headlines were reported in the last 48 hours for BRLS, so the 25.85% single-day drop cannot be attributed to a confirmed public announcement. The move likely reflects either delayed market reaction to earlier news, a technical breakdown, or undisclosed corporate event.

The absence of any headlines in the Yahoo Finance RSS feed in the 48 hours preceding this severe decline is notable and limits our ability to pinpoint a specific catalyst. For a stock experiencing a ranked top-16 daily loss of this magnitude, typical drivers would include negative earnings surprises, guidance cuts, regulatory setbacks, insider selling, or sector-wide pressure. Without access to recent press releases, SEC filings, or confirmed reports, we cannot definitively attribute the move to any particular event. It is possible the triggering news arrived outside the monitored feed window, or that the decline reflects accumulating concerns about the business that were previously disclosed. We simply lack sufficient information to identify the root cause with confidence.

SGBX

SG Blocks Inc

$1.49−$0.52

-25.8%

UAC.WT

$0.60−$0.20

-25.0%

FIXX

Homology Medicines Inc

$12.29−$4.07

-24.9%

FGL

Founder Group Limited Ordinary SharesIndustrials

$0.21−$0.07

-24.1%

NASDAQ · Mkt cap $475 K

Founder Group announced an investment in a Malaysian EV charging network operator on the same day the stock fell 24%, suggesting market skepticism about the capital allocation or deal terms rather than enthusiasm for the expansion into the EV sector.

The headline released at 12:30 UTC on August 25 announces Founder Group's investment in Nichcom Go Sdn. Bhd., which operates SpacePlus, an EV charging network. The timing is notable: the announcement came on the same trading day as a severe 24% decline, ranking the stock among the day's twenty worst performers. This inverse relationship between news and price action suggests the market viewed the announcement negatively rather than as positive expansion news. Possible interpretations include concerns about dilution from financing the investment, skepticism about the EV charging market opportunity relative to Founder Group's core EPCC solar PV business, questions about management's capital allocation discipline, or unfavorable terms disclosed in the full release. The headline excerpt provided does not include financial details, deal structure, or valuation that would be necessary to assess whether the market's reaction was warranted.

SMXT

Solarmax Technology Inc.Technology

$2.65−$0.80

-23.2%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours to explain the 23.19% drop in SMXT, so the cause remains unclear without additional information about market conditions or company-specific events.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for SMXT's sharp 23.19% decline. For a micro-cap solar technology stock like Solarmax, several common driver categories could explain such a move: broader sector weakness if renewable energy stocks faced selling pressure, negative commentary from analysts or institutional holders not yet reflected in major news feeds, insider selling or insider trading disclosures, short-seller reports targeting the stock, regulatory developments specific to solar or clean energy, or operational setbacks announced via press release or SEC filings that may not yet appear in aggregated news feeds. Without headline confirmation, attributing the move to any single cause would be speculation. The sheer magnitude of the drop and its ranking as the 21st biggest loser suggests either a company-specific shock or participation in a broader sector selloff, but the evidence does not establish which.

BPTH

Bio-Path Holdings Inc

$0.03−$0.01

-22.7%

ZCMD

Zhongchao IncHealthcare

$0.72−$0.21

-22.7%

NASDAQ · Mkt cap $6.2 M

No news headlines were reported in the last 48 hours for ZCMD, so the 22.68% drop cannot be directly attributed to a specific announcement. The move likely reflects technical selling, sector headwinds, or undisclosed company-specific developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to a concrete catalyst such as earnings, guidance, regulatory action, or corporate announcements. For a micro-cap stock trading at $0.72, common drivers of sharp single-day drops include technical chart breaks, short liquidations reversing, retail trading volatility, or delayed news that has not yet propagated through major financial media. Illiquid stocks at this price point are also prone to disproportionate moves on relatively modest volume shifts. Without headlines or structural context about ZCMD's business, sector, or recent performance, any specific explanation would be speculative.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.16−$0.04

-21.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 21.64% decline likely reflects either technical selling pressure, broader market sentiment on blank-check vehicles, or undisclosed developments in the SPAC warrant or rights market.

Iron Horse Acquisitions Corp. II Rights is a SPAC-related security, specifically a rights offering tied to a special purpose acquisition company. These instruments are highly sensitive to redemption activity, warrant arbitrage unwinding, and shifts in investor appetite for blank-check deals. The absence of any news headlines in the last 48 hours means the move cannot be anchored to a specific corporate announcement, regulatory filing, or deal update. The decline could reflect general SPAC malaise, a spike in redemption pressure ahead of a shareholder vote, deterioration in the underlying acquisition target's negotiation status, or simply technical selling as the security trades at a very low price point where liquidity and volatility tend to be high. Without headline confirmation, any specific cause remains inference.

GIBO

Bukit Jalil Global Acquisition 1 Ltd.Communication Services

$30.50−$6.76

-20.9%

NASDAQ · Mkt cap $79 M

No news headlines were found in the last 48 hours to explain GIBO's 20.86% decline, making the direct cause unclear without additional information.

GIBO is a blank-check acquisition company listed on NASDAQ, and the absence of any news in the RSS feed over the past two days is notable given the severity of the move. For a SPAC or similar acquisition vehicle, sharp declines typically stem from deal timeline delays, target company complications, regulatory hurdles, shareholder meeting outcomes, or redemption pressure ahead of a merger vote. It is also possible the decline reflects broader market weakness on that specific date, a technical or short-covering event, or a delayed announcement not yet indexed by Yahoo Finance RSS. Without access to current market data, SEC filings, or company press releases from August 25, 2026, the precise catalyst remains speculative.

SDST

Stardust Power Inc.Industrials

$0.41−$0.10

-20.4%

NASDAQ · Mkt cap $8.6 M

No news headlines were found in the last 48 hours to explain the 20% drop in SDST, making the precise catalyst unclear without access to real-time market activity or company announcements.

Stardust Power Inc. declined sharply on August 25 with zero news coverage in the immediate 48-hour window. For a microcap stock trading near $0.41, price movements of this magnitude can occur from several generic categories: technical selling or profit-taking following a prior run, a delayed or breaking news item not yet indexed by Yahoo Finance, volume concentration among retail or algorithmic traders, or sector-wide weakness in power or energy stocks. Without access to intraday market data, social media mentions, earnings announcements, insider transactions, or broader market context, identifying the specific trigger is not possible. The absence of any headline is itself notable and suggests the move may be driven by technical factors, thin liquidity, or an announcement that has not yet propagated to major news feeds.

QLEP.WT

Quantum Leap Acquisition Corp WT

$0.12−$0.03

-19.9%

ETS

ELITE EXPRESS HOLDING INCIndustrials

$0.80−$0.20

-19.7%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours for ETS, so the 19.67% decline cannot be attributed to a specific disclosed event; the drop may reflect technical selling, delayed market reaction to an earlier announcement, or sector headwinds.

The absence of any recent news headlines makes it impossible to identify a concrete catalyst for Elite Express Holding's sharp 19.67% decline on August 25, 2026. Given that the stock trades on NASDAQ at $0.80, it occupies the micro-cap space where liquidity is often thin and price movements can be volatile even without news. Possible explanations, treated as inference rather than fact, include technical selling or momentum exhaustion after a prior rally, a delayed market reaction to company guidance or earnings released more than 48 hours ago, sector-wide weakness in logistics or transportation stocks, or trading activity driven by short-covering or options expiration mechanics. Without access to intraday volume data, broader market context, or company-specific information, the precise driver cannot be determined from the evidence provided.

CDT

Conduit Pharmaceuticals IncHealthcare

$2.03−$0.48

-19.1%

AIAI

AIAI Holdings CorporationIndustrials

$4.31−$1.01

-18.9%

NASDAQ · Mkt cap $367 M

No news headlines were available in the last 48 hours to explain AIAI's 18.93% single-day drop, making the precise trigger unknown without additional context or market data.

The absence of recent news coverage is striking given the magnitude of the decline; AIAI fell 18.93% to rank among the day's 30 biggest losers. This gap between a significant price move and zero reported headlines suggests either that the catalyst has not yet been formally announced or documented by financial news services, or that the move was driven by market dynamics rather than company-specific news. For an AI-focused holding company, typical catalysts might include disappointing earnings or guidance revision, competitive setbacks, sector-wide selloff, insider selling, or forced liquidations, but none of these can be confirmed from the available evidence. The lack of news also raises the possibility of technical selling, short covering reversal, or delayed reporting of an after-hours or pre-market event.

INAQ

INSU Acquisition Corp. II

$3.79−$0.87

-18.7%

XXII

22nd Century Group IncConsumer Defensive

$3.01−$0.67

-18.3%

NASDAQ · Mkt cap $1.4 M

No news headlines were found in the last 48 hours to explain the 18.29% drop, so the decline likely reflects either sector-wide selling pressure, technical weakness, or an unannounced development in this biotech/tobacco stock.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to point to a specific catalyst for the sharp 18.29% decline. 22nd Century Group is a publicly traded company focused on reduced-nicotine cigarettes and cannabis research, sectors that are subject to regulatory risk, sentiment shifts, and clinical or commercial setbacks that may not always be immediately reflected in widely syndicated news feeds. For a stock in this category trading at $3.01, plausible causes could include: an unfavorable regulatory announcement or delayed approval decision not yet widely covered, a significant institutional seller or short report circulating, general biotech or tobacco sector weakness, or a negative development disclosed via SEC filing or company announcement that has not yet reached major news aggregators. Without specific headline evidence, pinpointing the exact cause remains speculative.

LGVN

Longeveron Inc.

$0.69−$0.15

-18.0%

CUEN

Cuentas Inc.Technology

$0.51−$0.11

-17.7%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 17.71% drop cannot be attributed to a specific announced catalyst. The decline was likely driven by technical selling, market-wide pressure, or undisclosed company developments.

Cuentas Inc. fell 17.71% to $0.51 with no corresponding news coverage in the most recent 48-hour period according to available Yahoo Finance feeds. When a penny stock experiences a sharp single-day decline without identifiable public news, the most probable explanations fall into a few categories: technical selling or stop-loss cascades triggered by price levels, broad market weakness affecting smaller-cap or microcap stocks disproportionately, delayed reporting of company announcements not yet picked up by major news aggregators, or in some cases undisclosed material information that gradually enters the market. Without headline support, pinpointing the exact catalyst is speculative, though stocks at this price point tend to be sensitive to liquidity events and retail trading patterns.

SCTX

Scribe Therapeutics Inc.Healthcare

$30.87−$6.57

-17.5%

NASDAQ · Mkt cap $586 M

No headlines were found in the last 48 hours for Scribe Therapeutics, so the 17.55% drop cannot be directly attributed to disclosed news; the move likely reflects a market reaction to undisclosed developments, technical selling, or sector dynamics.

The absence of any news headlines in Yahoo Finance's RSS feed over the past 48 hours means we cannot point to a specific catalyst such as earnings, regulatory action, partnership announcement, or guidance change. For a biotech company like Scribe Therapeutics, which focuses on gene-editing therapeutics, sharp declines of this magnitude are typically triggered by clinical trial results, FDA feedback, insider selling signals, competitive announcements, or broader sector weakness in genomics stocks. Without access to real-time market alerts, social media activity, investor calls, or after-hours developments, we cannot determine which of these categories—if any—drove today's 17.55% loss. The move could also reflect momentum trading or technical breakdown if the stock was extended on relative strength.

SGLY

Singularity Future Technology Ltd.Industrials

$2.16−$0.46

-17.4%

NASDAQ · Mkt cap $2.7 M

SGLY dropped 17.42% with no news reported in the last 48 hours, making the catalyst unclear. The decline likely reflects either broader market weakness, a delayed earnings or guidance miss, or sector-specific headwinds affecting speculative tech stocks.

No headlines were found in the last 48 hours preceding this 17.42% decline, so the immediate trigger is not established by news. SGLY is a microcap tech-focused security trading at $2.16, making it susceptible to sharp moves on limited volume and retail sentiment shifts. For companies in this category, common drivers of sharp selloffs include disappointing quarterly results released before the news cycle captured them, analyst downgrades, warrant or convertible dilution announcements, trading halts being lifted, or contagion from weakness in correlated small-cap tech indices. Without access to earnings calendars, insider filings, or intra-day trading data, the specific catalyst cannot be pinned down from the available information alone.

TREO

Tactical Resources Corp.

$4.83−$1.01

-17.3%

LRHC

La Rosa Holdings Corp. - Common StockReal Estate

$0.50−$0.10

-17.2%

NASDAQ · Mkt cap $1.2 M

La Rosa reported improved first-half 2026 earnings with gross profit up 10% and operating loss down 42%, but also disclosed a recent Nasdaq compliance deficiency notice, likely triggering the 17% single-day sell-off as investors weighed operational progress against regulatory risk.

The company released two major announcements on August 24th. On the positive side, first-half 2026 results showed material improvement: gross margin expanded 329 basis points to 13.0%, operating expenses fell 25%, and net loss improved 9.4% to $15.6 million versus $17.2 million in the prior period. This represents genuine operational progress. However, the same day La Rosa announced receipt of a Nasdaq deficiency notice related to periodic filing requirements, though the company states it regained compliance by filing its second quarter 10-Q on time. The sharp 17% decline suggests the market weighted the compliance scare more heavily than the operational gains, or investors interpreted the deficiency notice as a sign of deeper governance or operational fragility despite stated resolution. Stocks trading near $0.50 are often highly sensitive to regulatory friction.

TONT.WT

Graf Global Corp.

$0.40−$0.08

-16.7%

AMPGZ

Amplitech Group, Inc. Series B Right

$0.22−$0.04

-16.7%

NASDAQ

AmpliTech announced three design wins for satellite communications components on the same day AMPGZ rights fell 16.66%, but the timing and absence of negative news suggest the drop was likely driven by technical factors, market conditions, or profit-taking rather than the announcement itself.

The headline from August 25 reports a positive business development: AmpliTech's AGMDC division secured three competitive design wins for GaAs MMIC components used in advanced phased-array satellite communications platforms. This is presented as performance-driven success that strengthens the company's market position. The announcement itself contains no negative information, no guidance reduction, no contract cancellation, and no adverse regulatory news. The 16.66% decline in AMPGZ (a Series B rights offering security) occurred on the same day as this positive announcement. This mismatch between positive news and negative price action suggests the decline was more likely driven by technical selling pressure, broader market weakness in micro-cap or NASDAQ small-cap names, or pre-existing momentum traders exiting positions. Rights offerings can be especially sensitive to technical factors and sentiment shifts independent of the underlying company news.

HODO

House of Doge Inc.Technology

$0.39−$0.07

-16.0%

NASDAQ · Mkt cap $33 M

No news headlines were available in the last 48 hours to explain the 15.96% drop in HODO stock, so the cause remains unclear from public information.

House of Doge Inc. fell 16% on August 25, 2026, but no recent news headlines were indexed to identify a specific catalyst. This absence of reportage is itself noteworthy given the stock's position as the 41st biggest loser of the day. For a stock trading at $0.39, typical drivers of sharp declines without headline coverage include retail trading volatility, technical chart breaks at key support levels, delayed or unconfirmed rumors not yet picked up by wire services, or sector-wide weakness that may have been reported on August 23 or earlier and is now being re-priced. Without access to the company's corporate filings, recent insider trading activity, or broker downgrades from the relevant timeframe, it is not possible to assign high confidence to any single explanation. The lack of news does not rule out company-specific developments; it may simply indicate a lag in news aggregation or that the move was driven by factors outside traditional financial media.

ARYD

ARYA Sciences Acquisition Corp IV

$0.55−$0.10

-15.4%

OLOX

Olenox Industries Inc.Industrials

$1.50−$0.27

-15.4%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours for OLOX, so the 15.35% drop cannot be attributed to a specific announced catalyst. The move likely reflects technical selling, broader market weakness, or untracked developments.

The absence of recent news in the Yahoo Finance RSS feed means we cannot identify a specific corporate event or announcement driving the decline. OLOX is a micro-cap stock trading at $1.50, a price range where volatility is typically high and liquidity can be thin. Stocks at this price level often move on technical factors such as support breaks, forced liquidations, short covering, or retail trading activity rather than fundamental news. It is also possible that relevant news exists but was not captured by the RSS feed, or that the move reflects a delayed market reaction to older developments. Without access to the company's recent filings, insider trades, or non-newswire announcements, we cannot rule out sector-wide headwinds, deteriorating fundamentals, or execution issues at the company itself.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.09−$0.02

-15.1%

NASDAQ · Mkt cap $4.8 M

RITR fell 15.07% on August 25th despite announcing a joint venture with Smart Pointer Logistics on August 24th valued at approximately HK$120 million, suggesting market skepticism about deal terms or broader sell-off pressure unrelated to the news.

The headline released on August 24th announced a five-year joint venture collaboration between Reitar and Smart Pointer Logistics for cold-chain fulfillment and digital supply chain capabilities in the Greater Bay Area, with an estimated contract value of HK$120 million. This is typically positive corporate development news. However, the stock dropped sharply the following day, which indicates either that market participants viewed the deal as dilutive, overvalued, or insufficient to justify the current valuation, or that the decline stems from an unrelated negative catalyst not captured in the provided headlines. For a micro-cap stock trading at $0.09, technical selling, index rebalancing, sector rotation, or undisclosed company-specific headwinds are all plausible but unconfirmed drivers. The disconnect between constructive M&A news and a same-day ranking as the 44th biggest loser suggests either negative sentiment about deal structure or a separate catalyst absent from this news feed.

FWACR

Futurewave Acquisition Corporation Rights

$0.17−$0.03

-15.0%

HVII

Hennessy Capital Investment Corp. VII Ordinary Shares

$7.82−$1.39

-14.9%

AMOD

Insight Acquisition Corp.Technology

$3.77−$0.65

-14.7%

NASDAQ · Mkt cap $22 M

Despite two positive news items about Alpha Modus's patent litigation win and grocery market partnership, AMOD fell 14.71%, suggesting the market either discounted the news or was driven by unrelated factors such as broader SPAC weakness or technical selling.

The two headlines released in the past 48 hours are both nominally positive for Alpha Modus: a federal court ruled in favor of the company's patent challenge against MNTN, and a new commercial partnership with Circle The Wagons targets the $353 billion independent grocery market with immediate deployment programs. However, the stock declined sharply on the day the first headline published, which is counterintuitive. This disconnect suggests either that investors viewed the news as priced in, lacked confidence in the company's ability to monetize litigation victories or partnerships, or that the move was driven by broader sector headwinds affecting SPACs or acquisition-stage companies. Without additional context on market sentiment toward the stock, insider activity, or competing negative developments not captured in the news feed, it is difficult to definitively attribute the decline to the published headlines.

GPUS

Hyperscale Data, Inc.Industrials

$0.40−$0.07

-14.5%

NYSE · Mkt cap $31 M

Hyperscale Data announced a $21.6M bitcoin treasury position today, yet the stock fell 14.51%, suggesting the market either viewed the announcement as dilutive, disappointing relative to expectations, or the decline was driven by unrelated sector or technical factors.

The headline announces Hyperscale Data's bitcoin holdings reaching $21.6M, which on its face is a positive narrative for a crypto-exposed equity. However, the stock dropped sharply the same day, creating a disconnect. This divergence can occur for several reasons: the market may have expected a larger treasury or a more bullish framing; the announcement may have revealed dilution or capital raises that offset the bitcoin value perception; or the decline may reflect broader weakness in crypto-linked equities or small-cap tech stocks on 2026-08-25 independent of this specific news. The second headline about FingerMotion and Lyken.AI appears unrelated to GPUS directly. Without additional context on valuation, share count changes, or competitive positioning, the precise mechanism linking the announcement to the sell-off remains unclear.

DFSCW

DEFSEC Technologies Inc.Industrials

$0.02−$0.00

-14.2%

GTERR

Globa Terra Acquisition Corporation Rights

$0.06−$0.01

-14.1%